AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
来源：Reuters发布于 2026-10-02
AstraZeneca and Daiichi Sankyo have entered into a clinical collaboration with Summit Therapeutics to test their cancer drug, Datroway, in combination with Summit's ivonescimab across multiple tum...
相关标的：AZN
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。